Facial recognition surveillance, powered by artificial intelligence, is being used — or misused — in cities worldwide.

A new method for reliably identifying the presence of beer or other malted foodstuffs in archaeological finds is described in a study published May 6, 2020 in the open-access journal PLOS ONE by Andreas G. Heiss from the Austrian Academy of Sciences (OeAW), Austria and colleagues.

When tested in brain cells and in a mouse model of Alzheimer's disease, a new compound significantly reduced the number of amyloid plaques in the brain, lessened brain inflammation and diminished other molecular markers of the disease.

The first study to report use of the rheumatoid arthritis drug anakinra to treat COVID-19 patients found that high-dose anakinra was safe and was associated with respiratory improvements and reduced signs of cytokine storm [1] in 72% (21/29) of patients, according to results from patients studied for 21 days (enrolled from 17 to 27 March 2020) in a Milan hospital, published in The Lancet Rheumatology journal.

Broad modifications to current standards for treating acute stroke patients during the COVID-19 pandemic may be needed to preserve health care resources, limit disease spread and ensure optimal care, according to a Loyola Medicine neurologist.

Arrows fired from longbows could penetrate right through the human skull creating small entry and large exit wounds.

We already know one thing about that pick: It would be a woman, as Biden pledged in a recent debate.

McDonald's said it had closed a restaurant in Guangzhou for diversity and inclusion training after an investigation confirmed social media reports it was barring "black people".

Sotiris Tsiodras has been rated the most popular person in Greece for helping the country avoid disaster.

Supermarkets that service people across hundreds of kilometres of NSW are still struggling to get the basics.

Sotiris Tsiodras has been rated the most popular person in Greece for helping the country avoid disaster.

Supermarkets that service people across hundreds of kilometres of NSW are still struggling to get the basics.

Sotiris Tsiodras has been rated the most popular person in Greece for helping the country avoid disaster.

Supermarkets that service people across hundreds of kilometres of NSW are still struggling to get the basics.

As a medical oncologist in Connecticut, Dr. Justin Persico was all too aware of the people he treats, who would be at greater risk for exposure to the virus.

Les services psychologiques devraient être intégrés dans le régime public pour bénéficier à l’ensemble de la population, plaide le PLQ.

What issues to consider when building and optimizing your B2B e-commerce strategy.

Keep on reading: M.R. Asks 3 Questions: Suchit Bachalli, CEO, Unilog

A group of North Melbourne footballers apologises for throwing a party at a Melbourne home last night, with the club saying it was "inappropriate in the current climate".

It's usually a glamorous event in front of a packed arena, but this year's NFL draft will be broadcast from nearly 200 locations to sports-starved fans.

"Little Eyes" puts the Argentinian surrealist alongside writers — Shirley Jackson, Toni Morrison — whose horrors expose the rotten parts of ourselves.

BlazeMeter offers a cross-enterprise test automation framework for the entire technical team (developers, devops, ops and QA) throughout the product development lifecycle. Run continuous or on demand testing for APIs, mobile apps and websites. Run from the cloud, on-premise or as a hybrid solution. Use with JMeter & Selenium WebDriver & integrate with your existing CI, CD & APM tools.

Brands can reach shoppers, drive traffic, and attribute sales through this performance marketing platform spanning the largest retail and travel sites.

The Troublemaker singer has spoken out after pranking his girlfriend on TikTok during lockdown

Fyusion's technology may not scream “artificial intelligence” to the general public, but it does provide an intuitive, lifelike experience for consumers. It's their consumer-friendly technology that makes Co-Founder, Pantelis Kalogiros's view on purchasing behaviour worth listening to - especially for those integrating AI into their commerce businesses.  

Keep on reading: M.R. Asks 3 Questions: Pantelis Kalogiros, Co-Founder & VP, Fyusion

COO, Chris Luttrell shares her wealth of information about the current state of fraud, what IDology research is revealing about patron's trust and the forecasted impact of recent privacy legislation on consumers and businesses.

Keep on reading: Quick Answers to Quick Questions: In Conversation with Chris Luttrell, COO, IDology

By Jennifer A. Davidson and Justine E. Johnson On February 21, 2020, FDA published a final rule that, effective March 23, 2020, amends the regulatory definition of “biological product” consistent with the statutory definition under the Biologics Price Competition and Innovation Act of 2009 (BPCIA), as amended by the Further Consolidated Appropriations Act, 2020 (FCAA),

The post FDA AMENDS THE DEFINITION OF “BIOLOGICAL PRODUCT” AND PREPARES FOR THE CONCLUSION OF A DECADE-LONG TRANSITION PERIOD appeared first on Kleinfeld Kaplan & Becker LLP.

Biotechnology/Chemical/Pharmaceutical Customer Partnership   Wednesday, June 8, 2011 Meeting  Madison Auditorium   Starting Time of 10:00 AM  United States Patent and Trademark Office Alexandria, Virginia  600 Dulany Street, Alexandria, VA,  Accessing the event: Double click on the link below (or copy it into your internet browser) https://uspto.connectsolutions.com/r80345544/ Click here   for detailed login instructions in MS Word.   […]

Energy and Commerce Chairman Frank Pallone, Jr. (D-NJ) and Ways and Means Chairman Richard E. Neal (D-MA) sent a letter to Health and Human Services (HHS) Secretary Alex Azar and Centers for Medicare & Medicaid Services (CMS) Administrator Seema Verma today raising a series of concerns over the methodology used to distribute and the lack of transparency into how COVID-19 relief funds and loans for health care providers are being spent.  “We write to raise serious concerns about the Provider Relief Fund and the Accelerated and Advance Payment Programs,” Pallone and Neal wrote.  “With respect to each, we are concerned about the lack of transparency with Congress and the American people about how funds are being spent or loans are being made.  We also have grave concerns regarding the methodology being used to distribute $175 billion Congress appropriated for the Provider Relief Fund.” The Chairmen’s letter documents concerns with how the programs are being run, in particular the Administration’s methodologies for distributing funding that has shortchanged a number of critical providers and makes clear that more transparency is needed for Congress to accurately assess the ongoing needs of health care providers as the COVID-19 crisis unfolds. “The Administration’s efforts to establish the Provider Relief Fund to date has been at best, a series of missteps, and at worst, a disregard of Congress’ intent for the program,” Pallone and Neal continued in their letter. Pallone and Neal wrote that when Congress passed the CARES Act, it was clear that the funding provided to HHS for the Provider Relief Fund was for the express purpose, “to prevent, prepare for, and respond to coronavirus.”  The two Chairs voiced concern that some of the funding formulas adopted to date fail to target funding based on the statutory framework relating to COVID-19 driven costs.  In fact, the Chairs write that the level of funding appears to be, “completely disconnected from need.” The Chairmen requested an immediate response from HHS regarding documents and information pertaining to the Provider Relief Fund and the Accelerated and Advanced Payment Program.  Pallone and Neal also wrote that if HHS is unable to immediately provide the information, it should provide a timeline of when the Committees would receive the requested information. While recognizing the incredible demands on the Department at this difficult time, the Chairmen emphasized that, “This crisis demands that we work swiftly and based on the best data available.  Currently, despite repeated requests, this Administration has prevented Congress from obtaining the data that the Department has available on funding for our health care system, data that is necessary to inform near future legislation.  We look forward to receiving this information so that we can conduct the business the American people expect of us.  We look forward to having you join us at the earliest possible date in each of our Committees to discuss these and other COVID-related issues.” To read the full letter, click HERE. ###

Trovagene (NASDAQ: TROV), which started out as a diagnostics company, has renamed itself Cardiff Oncology to better reflect its focus on the cancer drug it is advancing in three clinical trials. In 2017 the San Diego area-based biotech made the first step in its transformation into a drug development-focused organization, licensing rights to an investigational […]

The solutions enable continuous remote monitoring of body temperature and other vitals, either at home or in care centers, for clinical trials.

The data management solution is designed to help sponsors and CROs manage data more effectively, increasing cost efficiency and effectiveness.

Today’s guest post comes from Scott Dulitz, Chief Strategy Officer at TrialCard. Scott discusses how combining payer intelligence with market-leading technology can enhance patient access.

TrialCard recently acquired Policy Reporter, a healthcare software solutions company that provides payer intelligence to the biopharmaceutical, medical device, and diagnostics industries. To learn more, schedule a demo of Policy Reporter or contact Scott (scott.dulitz@trialcard.com).

You can also register for Trialcard’s upcoming webinar: Leveraging Payer Intelligence in Patient Service Programs.

Read on for Scott’s insights.
Read more »

Rumor has it that Spring has finally reached our worldwide headquarters here in beautiful downtown Philadelphia. (See photo at right.) While we wait to go outside, please enjoy this month’s selection of noteworthy news:

• The outlook for drug prices

• A outstanding (and free!) resource for tracking COVID-19 daily data

• What’s up with community oncology practices?

Plus, I share my favorite chart of 2020 (so far).

P.S. Join the more than 9,200 followers of my curated links to neat stuff at @DrugChannels on Twitter. My recent tweets have highlighted: Prime Therapeutics new gene therapy offering, AmerisourceBergen’s laudable deal with the Justice Department, the Costco/Instacart deal, Rite Aid’s new CEO, clinical trial trends, vaccine pricing, and much more! I have also been tweeting under-the-radar stories about how the coronavirus is affecting drug channels.

Tomorrow (May 1), Drug Channels Institute will host the first of two live video webinars: Industry Update and COVID-19 Impact: Retail & Specialty Pharmacies. We'll host the second video webinar—Industry Update and COVID-19 Impact: PBMs & Payers—on May 8. CLICK HERE TO LEARN MORE AND SIGN UP. Contact Paula Fein (paula@drugchannelsinstitute.com) for our special promo codes for multiple viewing sites. DCI will donate 20% of all profits from these events to The Center for Disaster Philanthropy’s COVID-19 Response Fund.

Read more »

The Association of Clinical Research Organizations (ACRO) is pleased to announce the expansion of its membership to include ERT, Oracle and Veeva. These new ACRO member companies, with their focus on digital technologies that enable global clinical trials, characterize the ongoing innovation and evolution of contemporary clinical research. ACRO now has 12 member companies.

Privately-held pharma and diagnostics firm Menarini Group has announced a definitive agreement to acquire…

Kellogg Brown & Root LLC (KBR), a global engineering, construction and services company based in Houston, pleaded guilty today to charges related to the Foreign Corrupt Practices Act (FCPA) for its participation in a decade-long scheme to bribe Nigerian government officials to obtain engineering, procurement and construction (EPC) contracts. The EPC contracts to build liquefied natural gas (LNG) facilities on Bonny Island, Nigeria, were valued at more than $6 billion.

The United States has intervened and filed a complaint in a qui tam suit accusing EMC Corp. of failing to disclose its commercial pricing practices during negotiation of its General Services Administration (GSA) contracts and of providing improper payments and other things of value to Systems Integrators and other Alliance Partners on contracts with government agencies.

Joseph P. Galichia, M.D. and Galichia Medical Group P.A., a Kansas cardiologist and his practice group, have agreed to pay the United States $1.3 million to settle claims that the physician and his group violated the False Claims Act between 2001 and 2006, by submitting false claims to Medicare.

An Iranian citizen and his Tehran business have been charged with purchasing helicopter engines and advanced aerial cameras for fighter bombers from U.S. firms and illegally exporting them to Iran using companies in Malaysia, Ireland and the Netherlands. Among the alleged recipients of these U.S. goods was an Iranian military firm that has since been designated by the United States for being owned or controlled by entities involved in Iran’s nuclear and ballistic missile program.

An Irish trading company and three of its officers have been charged with purchasing helicopter engines and other aircraft components from U.S. firms and illegally exporting them to Iran using companies in Malaysia and the United Arab Emirates. Among the alleged recipients of these U.S. goods was an Iranian military firm that has since been designated by the United States for being owned or controlled by entities involved in Iran’s nuclear and ballistic missile program.

"You will be starting your service at a time when your government is placing a new and long overdue value on the scientific skills you have developed in this program."

Endoscopic Technologies Inc. (Estech), a medical device manufacturer, has agreed to pay the United States $1.4 million to resolve civil claims in connection with the alleged promotion of its surgical ablation devices. Surgical ablation devices use focused energy to create controlled lesions or scar tissue on a patient’s heart or other organs.

The department filed a lawsuit in federal court in West Virginia alleging that MasTec Advanced Technologies willfully violated the Uniformed Services Employment and Reemployment Rights Act of 1994 by discriminating against a U.S. Army Reserve member on the basis of his military service and by failing to offer Burress an appropriate reemployment position when he returned from military service.

Shamai Kedem Leibowitz, aka Samuel Shamai Leibowitz, 39, of Silver Spring, Md., pleaded guilty in federal court in Greenbelt, Md., to a one-count information charging him with knowingly and willfully disclosing to an unauthorized person five FBI documents classified at the "secret" level that contained classified information concerning the communication intelligence activities of the United States.

The Department has reached a settlement in its lawsuit against MasTec Advanced Technologies on behalf of Eugene C. Burress, a U.S. Army Reserve member, alleging that MasTec willfully violated the Uniformed Services Employment and Reemployment Rights Act of 1994 (USERRA).

Nexus Technologies Inc., a Philadelphia-based export company, pleaded guilty today in connection with a conspiracy to bribe officials of the Vietnamese government in exchange for lucrative contracts to supply equipment and technology to Vietnamese government agencies, in violation of the Foreign Corrupt Practices Act (FCPA).

The suit, filed in U.S. District Court in Washington, alleges that KBR knowingly included impermissible costs for private armed security in billings to the Army.

U.S. District Judge Alexander Williams sentenced former FBI contract linguist, Shamai Kedem Leibowitz, aka Samuel Shamai Leibowitz, age 40, of Silver Spring, Md., today to 20 months in prison followed by three years of supervised release for unlawfully providing classified documents to the host of an Internet blog who then published information from those documents on the blog.